JUND expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.752190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.540000E-02
Normal-vs-Stage2
2.035400E-01
Normal-vs-Stage3
2.960800E-01
Normal-vs-Stage4
4.650400E-02
Stage1-vs-Stage2
9.159200E-01
Stage1-vs-Stage3
7.471000E-01
Stage1-vs-Stage4
1.134650E-01
Stage2-vs-Stage3
6.887200E-01
Stage2-vs-Stage4
1.543380E-01
Stage3-vs-Stage4
5.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.768210E-01
Normal-vs-AfricanAmerican
2.606400E-01
Normal-vs-Asian
7.611700E-02
Caucasian-vs-AfricanAmerican
5.375400E-01
Caucasian-vs-Asian
2.905400E-01
AfricanAmerican-vs-Asian
2.126800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.531190E-01
Normal-vs-Female
2.211600E-01
Male-vs-Female
5.059000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.240500E-03
Normal-vs-Age(41-60Yrs)
1.624180E-01
Normal-vs-Age(61-80Yrs)
1.889430E-01
Normal-vs-Age(81-100Yrs)
3.528800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.319200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.785600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.708200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.833200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.057400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.473550E-01
Normal-vs-Daily Drinker
1.014790E-01
Normal-vs-Weekly Drinker
7.875900E-02
Normal-vs-Occasional Drinker
2.500600E-01
Normal-vs-Social Drinker
2.376000E-01
Non Drinker-vs-Daily Drinker
1.585990E-01
Non Drinker-vs-Weekly Drinker
2.349800E-01
Non Drinker-vs-Occasional Drinker
1.817990E-01
Non Drinker-vs-Social Drinker
2.483400E-01
Daily Drinker-vs-Weekly Drinker
8.971800E-01
Daily Drinker-vs-Occasional Drinker
1.659790E-02
Daily Drinker-vs-Social Drinker
2.351600E-02
Weekly Drinker-vs-Occasional Drinker
2.517500E-02
Weekly Drinker-vs-Social Drinker
4.250400E-02
Occasional Drinker-vs-Social Drinker
9.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.050800E-01
Normal-vs-Grade 2
1.552420E-01
Normal-vs-Grade 3
2.206000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.117800E-01
Grade 1-vs-Grade 3
8.990400E-01
Grade 1-vs-Grade 4
3.050800E-01
Grade 2-vs-Grade 3
2.358800E-01
Grade 2-vs-Grade 4
1.552420E-01
Grade 3-vs-Grade 4
2.206000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.140960E-01
Normal-vs-NonDiabetic
1.580600E-01
Diabetic-vs-NonDiabetic
3.224800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.871900E-02
Normal-vs-NoPancreatitis
1.684370E-01
Pancreatitis-vs-NoPancreatitis
1.256360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.874500E-02
Normal-vs-N1
2.240200E-01
N0-vs-N1
3.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.441400E-01
Normal-vs-TP53-NonMutant
8.596800E-01
TP53-Mutant-vs-TP53-NonMutant
3.874000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
